UPDATE: Wedbush Downgrades Nightstar Therapeutics (NITE) to Neutral Following Acquisition

March 4, 2019 2:52 PM EST
Get Alerts NITE Hot Sheet
Price: $25.41 --0%

Rating Summary:
    2 Buy, 8 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - March 4, 2019 2:53 PM EST)

Wedbush analyst David Nierengarten downgraded Nightstar Therapeutics (NASDAQ: NITE) from Outperform to Neutral with a price target of $25.50.

For an analyst ratings summary and ratings history on Nightstar Therapeutics click here. For more ratings news on Nightstar Therapeutics click here.

Shares of Nightstar Therapeutics closed at $15.16 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades